confirms what we Knew
A new study published in the journal Vaccine examines the occurrence of serious adverse events following adult clinical trials of the Pfizer and Moderna mRNA COVID-19 vaccines.
Authored by researchers from the United States, Spain and Australia, the analysis reveals that,
Describing how their
results raise concern that mRNA vaccines are associated with more
harm than initially estimated at the time they were given emergency
authorization, the researchers say their findings point to the need
for formal harm-benefit analyses to be conducted.
Endorsed by the World Health Organization (WHO) and subsequently updated, the list contains potential adverse events relevant to COVID-19 vaccines.
The Vaccine journal researchers adapted the Brighton Collaboration list to evaluate serious adverse events of special interest observed in the Pfizer and Moderna mRNA COVID-19 vaccine trials.
They therefore sought to
investigate the association between mRNA COVID-19 vaccines
authorized by the United States Food and Drug Administration
and serious adverse events identified by the Brighton
Collaboration, using data from the randomized,
placebo-controlled clinical trials on which the authorizations were
The researchers found that the Pfizer trial exhibited a particularly notable 36 percent higher risk of serious adverse events occurring in the vaccine group compared to the placebo group.
The Moderna trial exhibited a 6 percent higher risk of such events occurring in the vaccine group compared to the placebo group.
Overall, compared to trial participants receiving placebos, the researchers found that the recipients of mRNA vaccines had a 16 percent higher risk of experiencing serious adverse events.
Such events included,
In the Pfizer trial, serious adverse events of special interest were reported in the vaccine group at a rate equivalent to 27.7 incidents per 10,000 people vaccinated.
For each 1 million people vaccinated, this would translate into an excess risk of 2,770 serious adverse events.
Compared to the placebo
group, people receiving the Pfizer vaccine had a 57
percent higher risk of experiencing a serious adverse event
of special interest.
For each 1 million people vaccinated, this would translate into an excess risk of 5,730 serious adverse events.
People receiving the
Moderna vaccine had a 36 percent higher risk of
experiencing a serious adverse event of special interest than those
in the placebo group.
Together, the Pfizer and Moderna vaccines were associated with an excess risk of serious adverse events of special interest equivalent to 12.5 per 10,000 people vaccinated.
For each 1 million people vaccinated, this would translate into an excess risk of 1,250 serious adverse events.
This is clearly contrary to what the general public has been led to believe.
As the researchers
correctly point out, rational health policy formation should
consider potential harms alongside potential benefits.
They add that full transparency of COVID-19 vaccine clinical trial data is needed to properly evaluate these questions.
While non-transparency might be in the financial interests of the vaccine industry, it most definitely isn't in the health interests of the general public.
If the companies
manufacturing mRNA vaccines really have nothing to hide, it's time
for them to come clean and prove it...!